Corporate
News Releases
2011
December
Corporate
Otsuka Welfare Clinic awarded special commendation by the Ambassador of Japan in Pakistan Otsuka Welfare Clinic recognized for providing treatment over the past eight years to Afghan refugees in Pakistan
Nutraceuticals
Survey of bowel movements and fiber intake among children Approximately 40% of elementary school children do not have daily bowel movements Approximately 60% of mothers in this group feel their children lack fiber
November
Pharmaceuticals
New Drug Application for Otsuka's Once-monthly Aripiprazole Depot Formulation for Maitenance Treatment of Adult Patients With Schizophrenia Accepted for Review by the U.S. Food and Drug Administration
Pharmaceuticals
Streptococcus pneumoniae Kit “RAPIRUN S. pneumoniae HS (otitis media/sinusitis)” as in vitro diagnostic releases on December 1
Corporate
Tokushima Itano Factory jointly Sponsors Asan Walking Festival in Itano and Appeals for the Importance of Environmental Protection and Health
Corporate
OTSUKA PHARMACEUTICAL CO., LTD. AND H. LUNDBECK A/S Sign Historic Agreement to Deliver Innovative Medicines with Focus on Psychiatric Disorders Worldwide
Pharmaceuticals
Results of two trials show a rapid and sustained response with certolizumab pegol for treatment of rheumatoid arthritis (J-RAPID and HIKARI Studies) released at 2011 meeting of American College of Rheumatology (ACR)
October
Nutraceuticals
Amino-Value Used as the Official Drink of the Osaka Marathon 2011 Otsuka Pharmaceutical is Now Supporting Two of Japan's Largest Civic Marathons Amidst an Unprecedented Boom in Popularity in Japan
Pharmaceuticals
Otsuka Pharmaceutical Confirmed Clinical Efficacy of Rotigotine Transdermal System for Restless Legs Syndrome in Phase III Clinical Study in Japan
September
Nutraceuticals
～Easy Meal Replacement for Calorie Control ～ No. 1*French Slimming Dietetic Food Market Brand Gerlinéa Launches Cereal Bar in Chocolate and Vanilla Flavors
Nutraceuticals
Low-GI biscuit packed with fiber and bursting with five-grain cereal crunch Gerblé GLUCOSANTE Launches on October 3
Nutraceuticals
Healthy hair begins with a healthy scalp. Start your care routine from the scalp with UL･OS. UL・OS Scalp Shampoo（Medicated Cosmetic）Launches on September 13
Corporate
Notice Regarding Change of Director on Board (PDF: 73.4 KB)
August
Nutraceuticals
How intense is trail walking in the mountains for older people? This research suggests that muscle fatigue after trail walking may be reduced by BCAA supplementation.
Corporate
The Core of Globally Expanding Drug Discovery Research 10th Research Center wins the "Nikkei New Office Promotion Award" The Creativity-producing Office Space is Evaluated
Corporate
25,000 People Gather in Hilly Town of 10,000 for Free Live Concert Held at Tokushima Wajiki Factory Event Dedicated to Vitalization of Local Community
Corporate
Otsuka Pharmaceutical Establishes Special Subsidiary Company, Heartful Kawauchi Co., Ltd., in Tokushima City to Promote Employment of Persons with Disabilities
Pharmaceuticals
In-vitro Diagnostic Kit, WT1 mRNA Assay Kit 'Otsuka' is Covered under Japanese Insurance Program, effective as of August.
June
Pharmaceuticals
The IFPMA Welcomes Otsuka Pharmaceutical as New Member to advance Global Health
Corporate
Otsuka Pharmaceutical Appoints Two Female Operating Officers for the First Time in the History of Its Pharmaceutical Business (PDF: 95.4 KB)
Corporate
Otsuka Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors (PDF: 38.7 KB)
Pharmaceuticals
Anti-cancer agent "Sprycel® 20mg Tablets and Sprycel® 50mg Tablets (dasatinib)" approved as the first-line treatment of chronic myeloid leukemia-A new treatment option for newly-diagnosed CML patients-
Pharmaceuticals
Otsuka receives approval for Streptococcus pneumoniae Kit "RAPIRUN S. pneumoniae HS (otitis media/sinusitis)" as in vitro diagnostic on June 13
Pharmaceuticals
Otsuka Announces Initiation of Phase I Clinical Trial for Therapeutic Cancer Vaccine OCV-105
Pharmaceuticals
Otsuka Pharmaceutical confirmed clinical efficacy of rotigotine trandermal system in Phase III clinical study in patients with advanced Parkinson's disease in Japan
May
Nutraceuticals
America's Number One-selling Vitamin, Mineral and Supplement Brand Five Years Running* - Nature Made New Series Providing Nutritional Support in a Single Tablet (or Softgel) Taken DailySuper Multiple Vitamin & Minerals and Super Fish Oil Set for June 6 Release
Nutraceuticals
Oronamin-C Drink First Small-Volume Vitamin Drink in Japan to Exceed 30 Billion Bottles in Accumulated Sales
Nutraceuticals
Gerlinéa, the No. 1 brand* for French Diet Food market ～Easy and Enjoyment; French Style Calorie Control～ Test Marketing Begins June 2, 2011 in Shizuoka and Tokyo
Corporate
Otsuka Pharmaceutical Establishes Subsidiary, Otsuka SA, to Facilitate Public Advocacy for the Company's Global Tuberculosis Program
Pharmaceuticals
Otsuka Pharmaceutical Co., LTD. Announces Results from a Phase 2 Study of Investigational Product OPC-34712 as Adjunctive Therapy in Adults with Major Depressive Disorder
Pharmaceuticals
Phase III Study Results for Rebamipide Ophthalmic Suspension for Dry Eye Announced at ARVO 2011
March
Pharmaceuticals
Otsuka Pharmaceutical Received Approval for Additional Indication of L-Cartin® tablets for Carnitine Deficiency in Japan
Corporate
Otsuka Pharmaceutical Announces Changes to Board Members (PDF: 58.5 KB)
Nutraceuticals
SOYJOY Fruity Tomato, a New Combination of Soy and Tomato, Launches on April 11
Corporate
Day Care Center for Children BeanStalk Kids Center TOKUSHIMA Opening April 1, 2011
February
Pharmaceuticals
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate Data from 52-week maintenance trial showed superiority of adjunctive ABILIFY versus adjunctive placebo on primary study endpoint
Corporate
Tokushima Itano Factory Awarded "Excellent Energy Management Factory" Commendation from Chief of Shikoku Bureau of Economy, Trade and Industry Achieves roughly 3.5% reduction in energy consumption efficiency unit
Pharmaceuticals
In-vitro Diagnostic Kit, WT1 mRNA Assay Kit 'Otsuka' Received Regulatory Approval for Additional Purpose of Use with Myelodysplastic Syndromes
Corporate
Otsuka Foods and Otsuka Pharmaceutical to Partner with ITO EN on Cross-Sales of Products in Vending Machines
Nutraceuticals
Sparkling Soy Water SOYSH Internet Buzz Leads to Its Distribution to Stores Nationwide in Japan Starting March 14, 2011
Pharmaceuticals
Otsuka Announces Initiation of Phase II Clinical Trials for Angiogenesis Inhibitor OCV-101
January
Nutraceuticals
Nutraceutical Business in Europe Moves to New Stage SOYJOY, the First Japanese Product, Set to Debut in 4 Countries
Pharmaceuticals
Otsuka Pharmaceutical Files for Additional Indication Regulatory Approval in Japan for ABILIFY®, a Treatment for the Manic Symptoms Associated with Bipolar Disorder
Nutraceuticals